Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).
- Conditions
- Heart Failure
- Interventions
- Other: Ultra Conservative ICD ProgrammingOther: Traditional ICD Programming
- Registration Number
- NCT01977703
- Lead Sponsor
- Vanderbilt University Medical Center
- Brief Summary
We propose to study a strategy empirically applied for the past 6 months at a high volume LVAD center (Vanderbilt Heart and Vascular Institute). This utilizes an ultra conservative device programming strategy to maximize battery longevity, avoid inappropriate implantable cardioverter defibrillator (ICD) therapy, improve quality of life through reduction in overall shock burden, and potentially avoid unnecessary device generator changes prior to transplant. Avoiding CIED (cardiac implantable electronic device) change out device procedures prior to transplant is desirable.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ultra Conservative ICD Programming Ultra Conservative ICD Programming ICD will be set to ultra conservative settings post LVAD implant. Traditional ICD Programming Traditional ICD Programming ICD will be set to pre-LVAD settings post LVAD implant.
- Primary Outcome Measures
Name Time Method Time to first ICD shock following LVAD implant Within 12 months following LVAD implant
- Secondary Outcome Measures
Name Time Method Frequency of ICD generator change prior to definitive therapy Within 12 months following LVAD implant Number of patients requiring ICD generator change
Hospitalization frequency for decompensated congestive heart failure Within 12 months following LVAD implant Number of hospitalizations
Cardiac implantable electronic device (CIED) battery voltage/estimated longevity changes Within 12 months following LVAD implant Battery voltage and battery life measured in days
Frequency of anti-tachycardia pacing (ATP) therapy administration for appropriate or inappropriate arrhythmia detection Within 12 months following LVAD implant Number of ATP occurrences
Frequency of arrhythmic syncope Within 12 months following LVAD implant Number of syncope occurrences
Determine survival to heart transplantation following LVAD implant Within 12 months following LVAD implant Number of patients, post LVAD implant, to receive heart transplant and number of survival days post implant
Trial Locations
- Locations (1)
Vanderbilt University
🇺🇸Nashville, Tennessee, United States